Trending...
- Pastor Saeed Abedini Releases THE TRUTH – Volume 1, A Deeply Personal Story of Faith, Struggle, and Redemption
- $6 Million Funding Secured as Retail Expansion, Operational Streamlining, and Asset-Light Strategy Position the Company for Accelerated Growth $SOWG
- Training Lofts Launches $1,099 Unlimited Training Membership Featuring Semi-Private Coaching, Nutrition Support, and Recovery Services
MIAMI - Missouriar -- Diveroli Investment Group ("DIG") today announced that it has filed a Schedule 13D with the U.S. Securities and Exchange Commission disclosing a significant ownership position in PetMed Express, Inc. ("PetMed" or the "Company").
DIG believes PetMed's current share price is materially disconnected from the Company's intrinsic value. With multiple acquisition proposals on the table, significant hard assets on the balance sheet, no long-term debt, and a nationally recognized brand operating in a multi-billion dollar U.S. pet industry, DIG is calling on PetMed's Board of Directors to act decisively in the best interests of all shareholders.
In late 2025, PetMed received multiple unsolicited, all-cash acquisition proposals at prices well above the current trading level, including a $4.25 per share proposal from Cardone Ventures and a $4.00 per share proposal from SilverCape Investments, underscoring the strategic value of the Company's platform, brand, and customer base.
"With multiple cash proposals, it's clearly an attractive target for acquirers," said DIG Chief Investment Officer Aharon Diveroli. "When private capital is willing to pay 40% premiums, it's incumbent on management to explain why shareholders should wait."
More on Missouriar
PetMed's 184,000+ square foot headquarters and fulfillment center in Delray Beach, Florida - acquired in 2016 for $18.5 million - is a significant asset. South Florida industrial real estate has appreciated significantly since then. At roughly $2.90-$3.00 per share, investors are assigning minimal value to PetMed's assets, customer base, and licensed pharmacy platform - a clear case of market undervaluation during a transition period.
"Pet ownership and associated spending has shown durable growth across economic cycles" added DIG Chief Operating Officer Jonathan Berney. "U.S. expenditures grew annually at roughly 7-8% the past decade and are projected to surpass $150 billion in the next few years. Pet moms and dads continue to drive recurring demand."
Investor & Media Relations
Avigail Diveroli, Communications Director
Diveroli Investment Group
Email: avigail@investdig.com
Website: www.investdig.com
Important Additional Information and Where to Find It
More on Missouriar
The views expressed in this press release reflect the personal opinions of the authors or speakers and are based solely on publicly available information believed to be reliable at the time of publication. This communication is not a recommendation to buy, sell or exchange any securities, and it does not constitute an offer to sell or buy or the solicitation of an offer to buy or sell any securities. Information about PetMed Express is available at the SEC's website at www.sec.gov. We are not broker-dealers or registered investment advisors. Although we possess PETS shares, we may buy or sell shares at any time without notice.
Any statements about valuation, performance, or outlook are personal opinions and should not be construed as facts. Always conduct your own due diligence and consult a licensed financial advisor before making investment decisions. Compensation may have been provided to third parties involved in the creation or promotion of this content. All material is for informational and educational purposes only.
DIG believes PetMed's current share price is materially disconnected from the Company's intrinsic value. With multiple acquisition proposals on the table, significant hard assets on the balance sheet, no long-term debt, and a nationally recognized brand operating in a multi-billion dollar U.S. pet industry, DIG is calling on PetMed's Board of Directors to act decisively in the best interests of all shareholders.
In late 2025, PetMed received multiple unsolicited, all-cash acquisition proposals at prices well above the current trading level, including a $4.25 per share proposal from Cardone Ventures and a $4.00 per share proposal from SilverCape Investments, underscoring the strategic value of the Company's platform, brand, and customer base.
"With multiple cash proposals, it's clearly an attractive target for acquirers," said DIG Chief Investment Officer Aharon Diveroli. "When private capital is willing to pay 40% premiums, it's incumbent on management to explain why shareholders should wait."
More on Missouriar
- Melzi Job Coach Launches on iOS and Android: A Privacy-First AI Career Engine Built for Execution
- Columbia: Alley and sidewalk closure on South Ninth Street, March 17-19
- ACC ST: Solidifies Global Leadership with Consecutive Award-Winning, Immersive Programming
- 24/7 naloxone boxes available in several City of Columbia locations
- Training Lofts Launches $1,099 Unlimited Training Membership Featuring Semi-Private Coaching, Nutrition Support, and Recovery Services
PetMed's 184,000+ square foot headquarters and fulfillment center in Delray Beach, Florida - acquired in 2016 for $18.5 million - is a significant asset. South Florida industrial real estate has appreciated significantly since then. At roughly $2.90-$3.00 per share, investors are assigning minimal value to PetMed's assets, customer base, and licensed pharmacy platform - a clear case of market undervaluation during a transition period.
"Pet ownership and associated spending has shown durable growth across economic cycles" added DIG Chief Operating Officer Jonathan Berney. "U.S. expenditures grew annually at roughly 7-8% the past decade and are projected to surpass $150 billion in the next few years. Pet moms and dads continue to drive recurring demand."
Investor & Media Relations
Avigail Diveroli, Communications Director
Diveroli Investment Group
Email: avigail@investdig.com
Website: www.investdig.com
Important Additional Information and Where to Find It
More on Missouriar
- American Properties Realty, Inc. Leadership Attends NAHB International Builders' Show in Florida
- Certified Trading Card Association Names TradingCardsMarketplace.com a CTCA Preferred Marketplace
- $317M Revenue and a Clear Path to $1B: $IQST is Positioned for a Major Profitability Inflection
- ASI Hosts 2026 Executive Business Summit for Global Partner Community
- Pastor Saeed Abedini Releases THE TRUTH – Volume 1, A Deeply Personal Story of Faith, Struggle, and Redemption
The views expressed in this press release reflect the personal opinions of the authors or speakers and are based solely on publicly available information believed to be reliable at the time of publication. This communication is not a recommendation to buy, sell or exchange any securities, and it does not constitute an offer to sell or buy or the solicitation of an offer to buy or sell any securities. Information about PetMed Express is available at the SEC's website at www.sec.gov. We are not broker-dealers or registered investment advisors. Although we possess PETS shares, we may buy or sell shares at any time without notice.
Any statements about valuation, performance, or outlook are personal opinions and should not be construed as facts. Always conduct your own due diligence and consult a licensed financial advisor before making investment decisions. Compensation may have been provided to third parties involved in the creation or promotion of this content. All material is for informational and educational purposes only.
Source: Diveroli Investment Group
0 Comments
Latest on Missouriar
- Buildout Launches CRM, Completing the Industry's First AI-Powered End-to-End Deal Engine for CRE
- Energywise Solutions and Pickleball Pros Partner to Bring More Energy and Visibility to Pickleball Clubs
- The Franchise King® Releases Free Guide for Nervous Buyers
- Kanguro Insurance Taps Paylode to Launch Best-in-Class Pet and Renters Insurance Rewards Experience
- CCHR: CIA Mind-Control Files Raise Urgent Questions as Millions Take Psychotropic Drugs
- NRx Pharmaceuticals Launches Breakthrough One-Day Treatment Clinic in Florida as FDA Pathway and Clinical Data Strengthen Growth Outlook; $NRXP
- Revenue Optics Launches Talent Infrastructure Platform for SaaS Revenue Hiring and Appoints Sabz Kaur to Lead Growth
- Building a Multi-Domain Autonomous Systems Platform at the Intersection of AI, Defense and Infrastructure: VisionWave Holdings (N A S D A Q: VWAV)
- Bent Danholm Named "Top Luxury Real Estate Leader" in Modern Luxury Miami
- Author Ken Mora to Celebrate New Caravaggio Book Debut with Special Event at Palazzo Venezia Naples
- Matthew Sisneros Releases Raw and Unfiltered Memoir: The Devil Lost Another One — A Powerful Story of Crime, Consequence, and Redemption
- From Life to Light: Jess L. Martinez Shares a Soulful Poetry Collection That Explores What It Means to Be Human
- St. Louis: City Transitions Private Property Assistance Program from Application Phase to Property Review and Prioritization
- Lawsuit Filed Against Boeing Over Defective Seat Switch on Boeing 787
- Quadcode Acquires Significant Stake in Game 7, LLC - The Parent Company for FPFX Tech and PropAccount.com
- City of Columbia receives Award for Outstanding Achievement in Popular Annual Financial Reporting
- Danholm Collection Announces Sale of 16689 Broadwater Ave in Winter Garden, Highlighting Strong Performance in Twinwaters Community
- City of Columbia to host second Community Summit March 14
- Strong Clinical Results for Breakthrough Liver Diagnostic Platform; ENDRA Life Sciences (N A S D A Q: NDRA) $NDRA
- 46th International Symposium On Forecasting – Dates, Venue And Speakers Announced